Filtros de búsqueda

Lista de obras de Michael S Hofman

'Hot spot' cardiac ischemia imaging with fluorodeoxyglucose positron emission tomography

artículo científico publicado en 2016

(18)F-fluorodeoxyglycose-avid thyroid incidentalomas: the importance of contextual interpretation

artículo científico publicado en 2017

18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

artículo científico publicado en 2019

64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

scientific article published on 15 November 2018

68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer.

artículo científico publicado en 2017

68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends

artículo científico publicado en 2017

A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy

artículo científico publicado en 2019

A Self-Fulfilling Prophecy: Comparing 177Lu-PSMA Radioligand Therapy in Taxane-Naïve Versus Posttaxane Metastasized Prostate Cancer Patients?

scientific article published on 29 March 2019

A pilot study of cardiopulmonary exercise testing and cardiac stress positron emission tomography before major non-cardiac surgery

artículo científico publicado en 2018

A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer

artículo científico publicado en 2014

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial pr

artículo científico publicado en 2018

ACCURACY OF DOSE CALIBRATORS FOR GALLIUM-68 PET IMAGING: UNEXPECTED FINDINGS IN A MULTI-CENTRE CLINICAL PRE-TRIAL ASSESSMENT.

artículo científico publicado en 2018

Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging

scientific article published on 15 June 2018

An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging

artículo científico publicado en 2013

Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience.

artículo científico publicado en 2007

Automatic delineation of functional lung volumes with 68Ga-ventilation/perfusion PET/CT.

artículo científico publicado en 2017

Breast lymphatic drainage via the pulmonary lymphatic system

artículo científico publicado en 2010

Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer

artículo científico publicado en 2017

Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series

scientific article published on 11 June 2019

Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study

artículo científico publicado en 2020

Correlation of 68Ga Ventilation-Perfusion PET/CT with Pulmonary Function Test Indices for Assessing Lung Function

artículo científico publicado en 2015

Detection of Synchronous Primary Malignancies with 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients

artículo científico publicado en 2017

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions

artículo científico publicado en 2017

Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning

artículo científico publicado en 2015

Does PET SUV Harmonization Affect PERCIST Response Classification?

artículo científico publicado en 2016

Dosimetry of Lu-177 PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pre-therapeutic imaging and "whole body" tumor dosimetry with treatment outcomes

scientific article published on 05 October 2018

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program

artículo científico publicado en 2017

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

artículo científico publicado en 2016

Editorial Comment

artículo científico publicado en 2019

Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) for Functional Metastatic Paraganglioma and Phaeochromocytoma

artículo científico publicado en 2017

Estimating lung ventilation directly from 4D CT Hounsfield unit values

artículo científico publicado en 2016

Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer

scientific article published on 14 January 2020

FDG PET in follicular lymphoma: more than a staging test?

scientific article published on 16 January 2017

Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours

artículo científico publicado en 2015

Fluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?

artículo científico publicado en 2011

Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis

artículo científico publicado en 2018

Gallium-68 EDTA PET/CT for Renal Imaging

artículo científico publicado en 2016

Gallium-68 Prostate-Specific Membrane Antigen PET Imaging

artículo científico publicado en 2017

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and

scientific article published on 14 February 2019

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation

artículo científico publicado en 2017

Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team

artículo científico publicado en 2019

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

artículo científico publicado en 2019

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

artículo científico publicado en 2015

Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)

scientific article published on 20 October 2018

How We Read Oncologic FDG PET/CT

artículo científico publicado en 2016

Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study

artículo científico publicado en 2019

Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin

artículo científico publicado en 2016

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

artículo científico publicado en 2013

Intra-individual comparison of Ga-PSMA-11 and F-DCFPyL normal-organ biodistribution

artículo científico publicado en 2019

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies

scientific article published on 08 October 2019

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting

scientific article published on 31 August 2020

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol

scientific article published on 01 November 2019

Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT)

artículo científico publicado en 2015

Monitoring DNA Damage and Repair in Peripheral Blood Mononuclear Cells of Lung Cancer Radiotherapy Patients

artículo científico publicado en 2020

Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma

artículo científico publicado en 2015

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy

scientific article published on 05 September 2019

Neuraxial Anesthesia Reduces Lymphatic Flow: Proof-of-Concept in First In-Human Study

artículo científico publicado en 2016

PET screening for metastatic colorectal adenocarcinoma

PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment

scientific article published on 12 June 2019

PET/CT Lung Ventilation and Perfusion Scanning using Galligas and Gallium-68-MAA

artículo científico publicado en 2018

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics

artículo científico publicado en 2018

Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy

scientific article published on 13 December 2018

ProPSMA: a callout to the nuclear medicine community to change practice with prospective, high-quality data

scientific article published on 03 April 2020

Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617

scientific article published on 05 March 2020

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

scientific article published on 11 September 2019

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

artículo científico

Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics

artículo científico publicado en 2019

Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.

artículo científico publicado en 2018

Prostate-specific membrane antigen from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer

artículo científico publicado en 2017

Prostate-specific membrane antigen theranostics: therapy with lutetium-177.

artículo científico publicado en 2017

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic

scientific article published on 12 February 2020

Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France

artículo científico publicado en 2015

Reduced ventilation-perfusion (V/Q) mismatch following endobronchial valve insertion demonstrated by Gallium-68 V/Q photon emission tomography/computed tomography

artículo científico publicado en 2017

Role of PET/CT in multimodality imaging in differentiating cardiac sarcoidosis from arrhythmogenic right ventricular dysplasia

scientific article published on 26 July 2018

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT.

artículo científico publicado en 2014

Special delivery: getting radiation to the target in diffuse large B-cell lymphoma

artículo científico publicado en 2012

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

scientific article published on 29 June 2018

Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart

artículo científico publicado en 2019

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

artículo científico publicado en 2018

The Australasian Radiopharmaceutical Trials Network (ARTnet) - Clinical Trials, Evidence and Opportunity

artículo científico publicado en 2020

The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma

scientific article published on 01 November 2019

The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging

artículo científico publicado en 2019

The evolving definition of bulky disease for lymphoma

artículo científico publicado en 2020

The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!

artículo científico publicado en 2019

The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer

scientific article published on 01 November 2019

TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

scientific article published on 22 October 2019

Tumour Heterogeneity and Resistance to Therapy in Prostate Cancer: A Fundamental Limitation of Prostate-specific Membrane Antigen Theranostics or a Key Strength?

artículo científico publicado en 2019

Use of PSMA PET/CT in Response Assessment Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer

artículo científico publicado en 2020

Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma

artículo científico publicado en 2010

Utility of 68 Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma.

artículo científico publicado en 2017

Validating and improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using 68Ga-labeled nanoparticles

artículo científico publicado en 2014

Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung

artículo científico publicado en 2015

Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework

scientific article published on 28 January 2019

What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply

artículo científico publicado en 2019

Where to Next for Theranostics in Prostate Cancer?

scientific article published on 29 March 2019

[177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer - Author's reply

scientific article published on 01 August 2018